UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000031857
Receipt number R000036377
Scientific Title A multi-center proof-of-concept phase2 study of encorafenib + binimetinib + cetuximab in patients with BRAF non-V600E mutated metastatic colorectal cancer
Date of disclosure of the study information 2018/04/01
Last modified on 2023/07/21 13:45:40

No. Disposal Last modified on Item of update
1 Insert 2018/03/23 12:03:04
2 Update 2018/09/19 08:38:30 Recruitment status
3 Update 2018/10/05 11:06:24 Institutions
4 Update 2023/07/21 13:45:40 Recruitment status
Date of IRB
Last follow-up date